Search

Your search keyword '"Davies, Faith E"' showing total 326 results

Search Constraints

Start Over You searched for: Author "Davies, Faith E" Remove constraint Author: "Davies, Faith E" Database ScienceDirect Remove constraint Database: ScienceDirect
326 results on '"Davies, Faith E"'

Search Results

3. Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

5. Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients

7. Chromothripsis as a pathogenic driver of multiple myeloma

13. Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

16. Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

17. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

18. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

23. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

28. Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial

29. Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

30. Tracking the Earliest Genomic Events in Multiple Myeloma Life-History

31. Genomic Determinants of Resistance in Newly Diagnosed Multiple Myeloma Treated with Targeted-Immunotherapy

32. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

33. Fc-Mediated Antibody Effector Function, Inflammation Resolution and Oligoclonality on TCR Rearrangements Predict Sustained MRD Negativity in Newly Diagnosed Multiple Myeloma Treated with Immunotherapy Regimens

42. Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation

44. Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

49. Whole-Genome Sequencing Reveals Distinct Mutational Signatures in Multiple Myeloma Patients with African Ancestry Compared with Those of Non-African Ancestry

Catalog

Books, media, physical & digital resources